These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Wong LL, Tanaka K, Lau L, Komura S. Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041 [Abstract] [Full Text] [Related]
3. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL. Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960 [Abstract] [Full Text] [Related]
4. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Sotiropoulos GC, Malago M, Molmenti EP, Radtke A, Brokalaki EI, Nadalin S, Lang H, Frilling A, Baba HA, Kühl H, Verhagen R, Broelsch CE. Eur J Med Res; 2005 Dec 07; 10(12):539-42. PubMed ID: 16356871 [Abstract] [Full Text] [Related]
5. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB. Ann Surg; 2008 Oct 07; 248(4):617-25. PubMed ID: 18936575 [Abstract] [Full Text] [Related]
6. Combined treatment, TACE and RF ablation, in HCC: preliminary results. Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y. Radiol Med; 2002 Oct 07; 104(5-6):412-20. PubMed ID: 12589262 [Abstract] [Full Text] [Related]
7. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation. Ashoori N, Bamberg F, Paprottka P, Rentsch M, Kolligs FT, Siegert S, Peporte A, Al-Tubaikh JA, D'Anastasi M, Hoffmann RT, Reiser MF, Jakobs TF. Digestion; 2012 Oct 07; 86(4):338-48. PubMed ID: 23207185 [Abstract] [Full Text] [Related]
8. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure? Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G. Eur J Gastroenterol Hepatol; 2008 Mar 07; 20(3):196-201. PubMed ID: 18301300 [Abstract] [Full Text] [Related]
9. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP. Liver Transpl; 2005 Dec 07; 11(12):1505-14. PubMed ID: 16315294 [Abstract] [Full Text] [Related]
10. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M. Liver Transpl; 2006 Aug 07; 12(8):1260-7. PubMed ID: 16826556 [Abstract] [Full Text] [Related]
11. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization. Chok KS, Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST. Arch Surg; 2006 Dec 07; 141(12):1231-6. PubMed ID: 17178966 [Abstract] [Full Text] [Related]
12. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Lao OB, Weissman J, Perkins JD. Clin Transplant; 2009 Dec 07; 23(6):874-81. PubMed ID: 19453644 [Abstract] [Full Text] [Related]
13. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, Desai NM, Chapman WC. J Am Coll Surg; 2006 Oct 07; 203(4):411-20. PubMed ID: 17000383 [Abstract] [Full Text] [Related]
14. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma]. Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ. Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642 [Abstract] [Full Text] [Related]
15. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]. Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW. Korean J Hepatol; 2009 Dec 23; 15(4):474-85. PubMed ID: 20037266 [Abstract] [Full Text] [Related]
16. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]. Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. Ai Zheng; 2005 Jul 23; 24(7):827-33. PubMed ID: 16004809 [Abstract] [Full Text] [Related]
17. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W. Liver Transpl; 2003 Jun 23; 9(6):557-63. PubMed ID: 12783395 [Abstract] [Full Text] [Related]
18. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D. Digestion; 2007 Jun 23; 75(2-3):104-12. PubMed ID: 17598962 [Abstract] [Full Text] [Related]
19. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC. Ann Surg Oncol; 2008 Nov 23; 15(11):3169-77. PubMed ID: 18696158 [Abstract] [Full Text] [Related]